Refer A Patient

Request An Appointment

Other

XOLAIR

XOLAIR (omalizumab) is a monoclonal antibody that helps decrease allergic responses in the body.
Infusion or injection therapy referral
What it treats Moderate to severe persistent Asthma & Chronic Idiopathic Urticaria (Hives)
Prescribed by Pulmonologists & Allergists
How it’s administered Subcutaneous injection
Frequency Every two to four weeks
Length of treatment 10 minutes or less

About This Therapy

XOLAIR (omalizumab) is a monoclonal antibody that helps decrease allergic responses in the body. Specifically, it is an anti-IgE antibody used for asthma and chronic idiopathic urticaria (hives).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

XOLAIR REFERRAL FORM

XOLAIR REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.
REFERRAL FORM →

Ready to refer a patient for XOLAIR

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.